Exam 1 Flashcards

1
Q

What makes up the PNS?

A
  • CN 3-12
  • spinal roots
  • peripheral nerves
  • the ANS
  • and muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a myopathy?

A

Disorder of muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the hallmark sign of myopathies?

A

Proximal muscle weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are signs and symptoms of myopathy

A
  • symptoms often vague
  • weakness = #1 sign
  • fatigue
  • muscle pain (myalgia)
  • cramps
  • urine discoloration secondary to myoglobin break down
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What lab values are associated with muscles being destroyed?

A
  • elevated CK levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Muscle fiber necrosis mean?

A

-the muscle fiber is destroyed but the support structure is intact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fiber disfiguration means

A

the structure or morphology is altered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gross abnormality mean

A

entire structure is changed. change in fiber type or type of connective tissue, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Electromyography (EMG)

A

using a needle to test the muscles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Muscular dystrophy (what is it, characteristics)

A
  • genetic disorder
  • characterized by progressive muscle weakness
    • – get degeneration and necrosis of skeletal muscle
    • – eventually replacement with adipose and fibrous tissue (calves pseudo hypertrophy)
  • DMD, Becker’s, Limb-girdle, and facioscapulohumeral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Duchenne MD

A
  • absent dystrophin (out of frame transcription)
  • most severe
  • X linked recessive (1 in 3500 males)
  • onset = early childhood
  • Rapid progression (3-6 yrs = gower’s sign, pseudo hypertrophy of calf; inc lordosis, mm imbalances, contractors. 12 yrs = w/c; teens-20 yrs = resp and cardiomyopathy. - > early death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Becker’s MD

A
  • reduced amount of dystrophin (in-frame transcription)
  • x linked recessive
  • milder and slower progression
  • onset = variable (usually 5-25 years)
  • **pelvic girdle weakness with waddling gait
  • normal life span unless cardiomyopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dystrophin

A

-a structural protein supporting sarcolemma needed for proper muscle structure.

Damage to the muscles lead to necrosis due to exceeding rate of repair. Collagen and adipose tissue take over muscle structure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Gower’s sign

A

getting up from the floor and needing to use arms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Limb-girdle MD

A
  • Autosomal dominant or recessive
  • autosomal recessive = most common
  • onset = 2 yrs-adult (male and females equal)

**Presentation: limb-girdle atrophy and weakness. Gluteals hip abd weakness. Can by highly variable progression.

**Pathology = loss of sarcoglycans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sarcoglycans

A
  • linked to dystrophin and help with structure/integrity of muscle.
  • loss of these results in limb-girdle MD.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Facioscapulohumeral

A
  • most common dominantly inherited dystrophy
  • 3rd most common inherited dystrophy
  • Pathology: something to do with chromosome 4

Signs: weakness of facial, shoulder girdle, prox arm muscles ( serrates, delts, traps, rhomboids)

  • normal lifespan
  • onset = variable (3-4th decade)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How can you treat dystrophies?

A
  • genetic counseling
  • potential new rx and research (stem cell, etc.)
  • pharmocological (cortisone, deflazacort, gentamyacin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a myotonia?

A
  • difficulty relaxing muscles, can be perceived as cramping
  • abnormality in ion channels and permeabilities of mm cell membranes -> excessive firing of action potentials -> hypertrophy

-repeated mm warming up gives some relief to stiffness

***affects distal muscles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Myotonic dystrophy

A
  • pathophys: myopathy is caused by mutation in gene for myotonic dystrophy protein kinase (DMPK)
  • genetic autosomal dominant

-affects multiple systems (cardiac conduction, gastric immobility, cognitive delays.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the presentation of myotonic dystrophy?

A

slow progressive weakness of eyelids, face and neck mm as well as distal mm

  • starts early teens with noticeable weakness of the hands and often foot drop.
  • neck muscles involved and SCM mms are often atrophic and poorly defined

-middle age = repeated falls. more mm involved. myotonia may diminish. facial weakness = swallowing difficulty and dislocation of the jaw

  • daytime somnolence and altered sleep patterns
  • ventilatory difficulties
  • cataracts common
  • endocrine abnormalities
  • cholecystitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

characteristics of myotonic dystrophy

A
  • long face: master and temporals atrophy
  • fully developed = eyes are hooded and mouth slacks. Muscle weakness is not limited to distal mm. Shoulder, hip, and leg weakness may be very prominent.

*ptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cushings syndrome

A

adrenal gland produces too much glucosteroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Addison’s disease

A

adrenal insufficiency. Electrolyte problem. general feeling of weakness and easily fatigued. BUT no objective mm weakness. impaired mm carbohydrate metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Graves’ disease

A

thyroid dysfunction. autoimmune. hyperthyroidism. Untreated 80% develop moderate mm weakness and atrophy especially shoulder girdle. prox UE, hip flexors, and pelvis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Acromegaly

A

pituitary dysfunction. Initial hypertroph and inc strength. later myopathy -> prox weakness and mm atrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are toxic myopathies?

A
  • drug induced
  • rhabdomyolysis
  • they are reversible if caught in time
28
Q

What are inflammatory myopathies?

A
  • characterized by mm weakness and myositis
  • acquired
  • precipitated by virus, bacteria, parasites, drugs, or idiopathic
  • polymyositis and dermatomyositis
  • HIV myopathy (arms > leg involvement)
29
Q

Post junction deficits

A

-Myesthenia gravis

30
Q

Prejunctional deficits

A

Lambert-Eaton

Botox

31
Q

Myesthenia gravis (what is it?)

A
  • Most common N-MJct disorder
  • acquired autoimmune disorder
  • dec # of ACh receptors on motor end plate
32
Q

Myasthenia graves (characteristics)

A
  • muscle weakness that fluctuates (fluctuating weakness with use and decrease weakness with rest)
  • early ocular signs (ptosis or diplopia)
  • can have pure ocular MG or mild generalized MG
  • Can influence CN 9-12
  • Mouth and pharyngeal weakness
  • normal cognition
  • exacerbations/remissions are typical
33
Q

Diagnosing myesthenia gravis

A
  • history of fluctuating weakness
  • tests for acetylcholine receptor binding antibodies
  • single fiber EMG 90% sensitivity
34
Q

Myasthenia gravis prognosis

A
  • 90% with ocular involvement (generalized weakness in 12 months)
  • max weakness in first 3 yrs
  • can have spontaneous improvement
  • active stage followed by inactive
  • fixed after 15-20 years

*symptoms can be exacerbated by systemic illness, pregnancy, menses inc in body temp, stress

35
Q

PT treatment of neuromuscular disorders

A
  • get near and respiratory baselines
  • swallow precautions (chin tuck)
  • energy expenditure
  • strenuous exercise controversial
  • *beware of myasthenia crisis (med emergency)
36
Q

When does a myasthenia crisis occur?

A
  • usually after surgery, acute infection, **rapid withdrawal of corticosteroids.
  • have rest failure from diaphragm weakness and severe oropharyngeal weakness leading to aspiration
37
Q

Lambert-Eaton Myasthenic syndrome

A
  • Presynaptic deficit
  • acquired autoimmune
  • ** antibodies interact with Ca++ channels
  • ~50% have underlying malignancy (usually small cell cancer of lungs)
  • diagnose with EMG
38
Q

Characteristics of Lambert-Eaton syndrome

A
  • Muscle weakness and fatiguability
  • LE >UE
  • *Weakness most severe in rested muscles
  • *Lambert sign = max grip inc in power over initial 2-3 seconds.
  • no CN involvement
  • hypoactive or absent reflex
  • metallic taste in mouth
  • autonomic dysfunction (dry mouth, constipation)
39
Q

Medical treatment of Lambert-Eaton

A
  • treat the cancer
  • Cholinesterace inhibitors (keeps ACh available for contractions)
  • immunosuppressive
40
Q

Bo-Tox

A
  • presynaptic deficit
  • ***prevents release of ACh
  • reduces hyperactivity of mm with spasticity
  • eventually get sprouting and re-innervation of nerve
41
Q

Epineurium

A
  • superficial layer
  • strong and mechanical resistant
  • loose connective tissues allows for movement and longitudinal stress
42
Q

Perineurium

A
  • middle layer

- not mechanical resistent

43
Q

Endoneurium

A

inner most layer

44
Q

Mechanisms of injury to peripheral nerves

A
  • traction
  • laceration
  • missile
  • compression
  • associated vascular injury (lack O2)
45
Q

Neuropraxia

A
  • mildest form
  • conduction is blocked -usually due to compression
  • fibers are not damaged
  • recover in about 4-6 weeks
46
Q

Axontomesis

A
  • More severe
  • Damage to axon (epineurium) but not the peri and endo
  • reversible injury
  • wallerian degeneration (1 mm/day)
47
Q

Neurotmesis

A
  • severest grade
  • axon, endo- and perineurium and myelin damaged.
  • all motor and sensory loss distal to lesion
  • irreversible injury without surgery.
48
Q

Wallerian degeneration

A

1) degeneration at nerve terminal
2) chromatolysis: changes in cell body swelling, nucleus and ER migrates more laterally
3) phagocytosis distal axon and myelin

49
Q

Bells palsy

A
  • CN7 injury
  • cannot close eyes (so have person try to close eyes to see if it was a stroke. if they close eye it was a stroke)
  • a neuropraxia
  • use facial grading scale
50
Q

Diabetic polyneuropathy

A
  • both myelin and axonopathy

- blood sugar influences the stuff. causes ischemia and axonal degeneration.

51
Q

Treat diabetic polyneuropathy

A
  • control blood sugar
  • exercise
  • foot care
  • orthosis
  • anodyne
52
Q

Alcoholic polyneuropathy

A
  • toxicity from alcohol
  • axonopathy potentially affecting myelin also
  • nutritional deficits (wt loss)
  • may have partial or full recovery
  • can affect arms. (diabetic is mostly foot)
53
Q

Charcot-Marie Tooth disease (CMT or HMSN)

A
  • genetic
  • slow progression
  • mostly hands and feet
  • probably axonopathy
  • distal (symmetric) limb weakness and atrophy
  • sensory loss (esp. proprioception)

-high arch, hammer toes, foot drop

54
Q

Guillian-Barre syndrome

A
  • AIDP vs. CIDP (acute and chronic inflam demyelinating polyneuropathy)
  • autoimmune from some virus
  • inflammation and demyelination of PNS
  • *initial sensory symptoms (esp distal)
  • rapid progressive weakness
  • max deficit in 4-14 days
  • weakness can lead to resp failure.
55
Q

Treatment for Guillian-Barre

A
  • plasmaphoresis
  • IVIG
    (corticosteroids give no added beneficial effects)
56
Q

Recovery from Guillian-Barre

A
  • begins 2-4 weeks after progression ceases
  • rapid
  • “Minimal residual deficits”
  • good prognosis

-virus attacks. myelin destroyed. repair is not the same. more nodes.

57
Q

CIDP (chronic inflammatory demyelinating polyneuropathy)

A
  • progressive weakness for 2 months
  • less frequent autonomic and respiratory involvement
  • preceding viral infections less common
58
Q

Disorder of anterior horn cell will result in what deficits?

A
  • sensory = intact
  • motor = impaired.

*weakness, coordination, dec tone, dec reflex, faciculations, fibulations.

59
Q

ALS: Amyotrophic lateral sclerosis

A
  • both an upper and lower motor neuron disorder.
  • after 40 y/o. Men: Women = 2:1
  • effects motor nerves in SC, Brain stem and cerebral motor cortex
60
Q

Characteristics of ALS

A
  • **1st sign = usually asymmetric weakness
  • often distal
  • extensors weaker than flexors esp in hands and C-spine.
  • mix of upper and lower motor neuron.
  • involves all striated mm
  • death due to resp impairments.
  • remain alert
  • life span ~ 5 yrs

*progressive degeneration of motor neurons. affects largest. get sprouting. reinnervation. Eventually cannot keep up.

61
Q

Progressive bulbar palsy

A
  • motor neurons of medulla oblongata
  • CN 9-12
  • multifactorial (immune, virus, toxins)

****glutamate defect ** problem with transport. too much causes Ca++ influx = bad. eventually neuronal death.

  • free radicals
  • SOD-1
  • clumping of neurofilaments
62
Q

Poliomyelitis

A
  • 3 strains of poliovirus
  • leads to inflammatory response.

1) virus invades ant horn cells
2) neuronal inflam
3) neuronal degeneration
4) paralysis, weakness

Recovery: full or partial. collateral sprouting.

63
Q

Post polio syndrome (PPS)

A
  • affects 2/3 people who had polio
  • appears 20-30 years after initial polio episode
  • fatigue and lack of endurance
  • new muscle weakness with or without mm atrophy
  • pain

Diagnosis: cluster of symptoms. prior poliomyelitis.

64
Q

2 components of post polio syndrome

A
  • PPMA (neurological manifestations -weakness)

- Musculoskeletal PPS (orthopedic manifestations -joint pain)

65
Q

Rabies (virus)

A
  • transported via PNS to CNS

- encephalitis

66
Q

Tetnus (bacterium)

A
  • retrograde transport to ant horn cells
  • > crosses synaptic cleft and gains access to CNS
  • > prevents release of GABA
  • > rigidity